Wilmette, IL, United States of America

Xian-Zhong Ding

This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xian-Zhong Ding. Retrieved from https://idiyas.com/inventor/xian-zhong-ding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xian-Zhong Ding: Innovator in Cancer Treatment

Introduction

Xian-Zhong Ding is a notable inventor based in Wilmette, IL (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of anti-cancer agents. His work focuses on utilizing materials derived from natural sources to combat cancer effectively.

Latest Patents

Xian-Zhong Ding holds a patent titled "Compositions and methods for the treatment and prevention of cancer." This invention relates to new classes of anti-cancer agents, providing materials that can be used alone or in combination with other therapies to enhance treatment efficacy. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Ding is affiliated with Northwestern University, where he conducts his research and collaborates with other experts in the field. His work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Some of his notable coworkers include Thomas E. Adrian and Peter Donald Collin. Their collaborative efforts contribute to the innovative research environment at Northwestern University.

Conclusion

Xian-Zhong Ding's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the medical field. His dedication to developing effective anti-cancer agents is paving the way for future advancements in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…